Claire Barton

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Luca Gianni, W. Eiermann, Alexey Manikhas et al. · The Lancet · 2010 · 1.2K citations

Noah Trial, Breast Oncology, Oncology +7

Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule

José Baselga, Xavier Carbonell, Noel-Jaime Castañeda-Soto et al. · Journal of Clinical Oncology · 2005 · 425 citations · Full text

Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer

U. Gatzemeier, G. Groth, Charles Butts et al. · Annals of Oncology · 2003 · 383 citations · Full text

Phase Ii Trial, Medicine, Metronomic Therapy +6

The epidermal growth factor receptor in human pancreatic cancer

Nicholas R. Lemoine, Christine M. Hughes, Claire Barton et al. · The Journal of Pathology · 1992 · 212 citations

Epidermal Growth Factor, Pancreatic Cancer, Histopathology +11

Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer

Claire Barton, Peter A. Hall, Christine M. Hughes et al. · The Journal of Pathology · 1991 · 211 citations